Technology | February 20, 2008

EVICEL Approved for Hemostasis in Surgery

In January the FDA granted Ethicon Inc. an expanded indication for EVICEL Fibrin Sealant (Human), which is one of the first fibrin sealants available as an adjunct to hemostasis for use in surgery, when control of bleeding by standard surgical techniques is ineffective or impractical.

EVICEL is an all-human, plasma-derived fibrin. It does not contain aprotinin, which has been associated with adverse health effects. The product is sold as a frozen liquid and requires less than one-minute preparation time after thawing.

February 2008

Overlay Init